2017 - Transplantation Science Symposium


This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA. Log in to view.

Tolerance

10.49 - Induction of Sensitization and Resistance to Transplant Tolerance by Allogeneic Pregnancy

Presenter: Ashley, Suah, Chicago, United States
Authors:

INDUCTION OF SENSITIZATION AND RESISTANCE TO TRANSPLANT TOLERANCE BY ALLOGENEIC PREGNANCY

AshleyN. Suah 0; JamesS. Young 0; Stella Hsu-Wei Khiew 0; Qiang Wang 0; Denping Yin 0; Maria-Luisa Alegre 0; AnitaS. Chong 0

4Department of Surgery, The University of Chicago Medicine, Chicago, IL, United States; 5Department of Medicine, The University of Chicago Medicine, Chicago, IL, United States

Introduction: Clinical data suggest allogeneic pregnancy is a sensitizing event[1][2]; yet, recent data from mouse models suggest it induces fetal-specific regulatory T cell (Treg) expansion and differentiation into memory Tregs that mediate systemic, fetal-specific immune regulation post-partum (PP)[3][4].  In this study, we sought to define the immunological consequences of allogeneic pregnancy for the induction of allograft tolerance in mice.

Methods: Virgin female B/6 mice were mated with male B/c-2W-OVA transgenic mice and conception date was confirmed with visualization of a copulation plug . Fetal-specific CD4+ and CD8+ T cell responses were tracked PP using 2W:I-Ab and OVA:Kb tetramers, and fetal-specific antibodies were monitored using B/c targets and flow cytometry. At PP day 30–45, F1 (B/6 x B/c)-2W-OVA heart transplants were performed and recipients were treated with anti-CD154 (POD 0, 7, 14) and donor-specific splenocytes (POD 0) to induce tolerance. Graft rejection was determined by direct palpation.

Results: PP females demonstrated a fifteen-fold increase in total number of fetal-specific Tregs and seven-fold increase in number of fetal-specific conventional CD4+ and CD8+ T cells (Tconvs) at PP day 30–45, compared to virgin controls. 2W:IAb CD4+ Tconvs showed modestly increased expression of markers of anergy (CD44+FR4+CD73+: 20% PP vs 6% V) and OVA:Kb CD8+ Tconvs markers of exhaustion (PD-1: 10% PP vs 0% V). Fetal-specific antibodies increased throughout pregnancy to a peak three-fold increase by PP day 30–45. 7 of 10 PP mice rejected their heart graft by day 21–28 post-transplant, while all virgin mice (N=25) accepted their grafts for > 60 days (Fig 1).

Conclusion: Despite sustained expansion of maternal FoxP3+ Tregs with fetal/allograft-specificity and acquisition of Tconvs with an anergic/exhausted phenotype, allogeneic pregnancy induced fetal-specific antibodies and a resistance to transplant tolerance.

{{AbstractFigure.1}}


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada